Cargando…
Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes
Background & Objective: Microvascular complications are the major outcome of type 2 Diabetes Mellitus progression, which reduce the quality of life, incur heavy economic burdens to the health care system and increase diabetic mortality. The aims of this study were to assess the prevalence of mic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publicaitons
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817776/ https://www.ncbi.nlm.nih.gov/pubmed/24353655 |
_version_ | 1782478127288549376 |
---|---|
author | Ali, Alia Iqbal, Farrukh Taj, Azeem Iqbal, Zafar Amin, Muhammad Joher Iqbal, Qasim Zafar |
author_facet | Ali, Alia Iqbal, Farrukh Taj, Azeem Iqbal, Zafar Amin, Muhammad Joher Iqbal, Qasim Zafar |
author_sort | Ali, Alia |
collection | PubMed |
description | Background & Objective: Microvascular complications are the major outcome of type 2 Diabetes Mellitus progression, which reduce the quality of life, incur heavy economic burdens to the health care system and increase diabetic mortality. The aims of this study were to assess the prevalence of microvascular complications among newly diagnosed type 2 diabetic patients and to analyze the association between these complications and poor glycemic control. Methods: This cross sectional hospital based study was carried out in Diabetic Clinic of Shaikh Zayed Postgraduate Medical Institute, Lahore Pakistan. The study was conducted from November 2011 to November 2012 among newly diagnosed type 2 diabetic patients. Relevant information of all patients was recorded with the help of a proforma. They were investigated for retinopathy, nephropathy and neuropathy. Results: We have divided the patients into two groups: Group I with good glycemic control (HbA(1)c <6.5) and group II with poor glycemic control (HbA(1)c >6.5). In group II microvascular complications were 89.8%. Neuropathy, nephropathy and retinopathy were present in 68.5%, 56.2% and 31.4% respectively. These similar percentages in Group I were 50%, 0% and 31% respectively and are significantly lower. Conclusion: The study showed that even in newly diagnosed type 2 diabetic patients who had poor glycemic control, frequency of microvascular complications is much higher as compared to those who had average glycemic control. Thus tight glycemic control does count even in newly diagnosed type 2 diabetics to prevent and minimize the occurrence of complications. |
format | Online Article Text |
id | pubmed-3817776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Professional Medical Publicaitons |
record_format | MEDLINE/PubMed |
spelling | pubmed-38177762013-12-18 Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes Ali, Alia Iqbal, Farrukh Taj, Azeem Iqbal, Zafar Amin, Muhammad Joher Iqbal, Qasim Zafar Pak J Med Sci Original Article Background & Objective: Microvascular complications are the major outcome of type 2 Diabetes Mellitus progression, which reduce the quality of life, incur heavy economic burdens to the health care system and increase diabetic mortality. The aims of this study were to assess the prevalence of microvascular complications among newly diagnosed type 2 diabetic patients and to analyze the association between these complications and poor glycemic control. Methods: This cross sectional hospital based study was carried out in Diabetic Clinic of Shaikh Zayed Postgraduate Medical Institute, Lahore Pakistan. The study was conducted from November 2011 to November 2012 among newly diagnosed type 2 diabetic patients. Relevant information of all patients was recorded with the help of a proforma. They were investigated for retinopathy, nephropathy and neuropathy. Results: We have divided the patients into two groups: Group I with good glycemic control (HbA(1)c <6.5) and group II with poor glycemic control (HbA(1)c >6.5). In group II microvascular complications were 89.8%. Neuropathy, nephropathy and retinopathy were present in 68.5%, 56.2% and 31.4% respectively. These similar percentages in Group I were 50%, 0% and 31% respectively and are significantly lower. Conclusion: The study showed that even in newly diagnosed type 2 diabetic patients who had poor glycemic control, frequency of microvascular complications is much higher as compared to those who had average glycemic control. Thus tight glycemic control does count even in newly diagnosed type 2 diabetics to prevent and minimize the occurrence of complications. Professional Medical Publicaitons 2013 /pmc/articles/PMC3817776/ /pubmed/24353655 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ali, Alia Iqbal, Farrukh Taj, Azeem Iqbal, Zafar Amin, Muhammad Joher Iqbal, Qasim Zafar Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes |
title | Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes |
title_full | Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes |
title_fullStr | Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes |
title_full_unstemmed | Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes |
title_short | Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes |
title_sort | prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817776/ https://www.ncbi.nlm.nih.gov/pubmed/24353655 |
work_keys_str_mv | AT alialia prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes AT iqbalfarrukh prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes AT tajazeem prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes AT iqbalzafar prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes AT aminmuhammadjoher prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes AT iqbalqasimzafar prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes |